TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.80nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9.5nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Antagonist activity at human FKBP12 measured after 30 mins by fluorescein labelled SLF tracer based fluorescence polarization assayMore data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 824nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 850nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 989nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.08E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.11E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.29E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.31E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.74E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Amplyx Pharmaceuticals
Curated by ChEMBL
Amplyx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.81E+3nMAssay Description:Antagonist activity at recombinant human N-terminal His6-tagged FKBP12 expressed in Escherichia coli assessed as inhibition of FK506 mediated FKBP12 ...More data for this Ligand-Target Pair